Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J0480 |
Short Description | Basiliximab |
Long Description | Injection, basiliximab, 20 mg |
Pricing indicator | 51 |
Coverage code | D |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 2006-01-01 |
Date Added | 2006-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
00078033184 | J0480 | Basiliximab | Simulect | NOVARTIS PHARMACEUTICALS CORPORATION | 20 MG | 1 | 1 | 1 | 1 |
00078039361 | J0480 | Basiliximab | Simulect | NOVARTIS PHARMACEUTICALS CORPORATION | 20 MG | 1 | 1 | 0.5 | 0.5 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 20 MG |
HCPCS/CPT Billing Units | 0.05 |
Total doses ordered | |
Billing Units | 0.05 |
Drug Details
-
Basiliximab injection is used with other medications to prevent immediate transplant rejection (attack of the transplanted organ by the immune system of the person receiving the organ) in people who are receiving kidney transplants. Basiliximab injection is in a class of medications called immunosuppressants. It works by decreasing the activity of the body's immune system so it will not attack the transplanted organ.